Latest CSL LIMITED(CSL) News
20 May 2026, 08:00 PM
CSL Canada is proud to recognize this important milestone of the first Canadian patient to receive HEMGENIX® (etranacogene dezaparvovec), the one-time gene therapy treatment for eligible patients living with hemophilia B, at London Health Sciences Centre in London, Ontario. Following a successful pa
11 May 2026, 10:38 PM
This article first appeared on GuruFocus.
CSL Ltd. (CMXHF) suffered its sharpest share-price drop on record after the Australian biotechnology company cut its full-year outlook, warned that its turnaround will take longer than expected, and flagged about $5 billion in additional non-cash, pre-tax i
04 May 2026, 11:40 PM
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Looking at the history of these tre
02 May 2026, 04:15 PM
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide.
CSL (ASX:CSL) has outlined a restructuring plan that includes separating its Seqirus influenza vaccine business into a standalone entity. The company is also
01 May 2026, 01:40 AM
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with CSL Limited Sponsored ADR (CSLLY) and Acadia Pharmaceuticals (ACAD). But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.
The best way